Join an exclusive panel discussion and networking event focused on "Fast-Tracking Clinical Development Through Australia - a strategic opportunity for Japanese biopharma companies". Hear from leading Australian clinical trials service providers and a Japanese sponsor about how streamlined processes, regulatory advantages, and deep therapeutic expertise in Australia can help accelerate your drug development pathway.
This is a must-attend event for Japanese biotech and pharma leaders exploring faster, cost-effective global development routes.
Presenting Organisations:
- Jane Kelly, CEO, CMAX Clinical Research
- Yvonne Lungershausen, CEO, Avance Clinical
- Amilia Wee, Senior Business Development Manager, Agilex Biolabs
Moderator:
- Dr Juran Kato, President and CEO, Gexval
Supported by the Government of South Australia
Date: Wednesday, 25 June 2025
Time: 3:00pm – 6:00pm (Doors open at 2:30pm) - Networking will follow the event with canapes and a selection of premium South Australian wines.
Venue:Australian Embassy Tokyo - 2 Chome-1-14 Mita, Minato City, Tokyo 108-8361
Cost: Free
RSVP: Thursday, 19 June 2025
Note #2: Capacity is limited to 100 people - tickets allocated via a lottery system 6:00pm Thursday 19 June 2025
Note #3: Photo ID (drivers' license, passport, health insurance card or foreigner's residence card) is required for access to Australian Embassy. Company ID/business cards are not acceptable
